Efficacy and safety of darunavir and etravirine in a patient with retroviruses and multiple virologic failure

Efficacy and safety of darunavir and etravirine in a patient with retroviruses and multiple virologic failure

Authors

  • Claudia Bernardini Clinica di Malattie Infettive e Tropicali, Università degli studi di Genova, Genova
  • Raffaella Rosso Clinica di Malattie Infettive e Tropicali, Università degli studi di Genova, Genova

DOI:

https://doi.org/10.7175/cmi.v3i3.546

Keywords:

Antiretroviral regimen, Resistance, Etravirine, Darunavir

Abstract

Drug resistance to antiretroviral regimen is a challenging problem in HIV-infected patients. We describe a case of a 45-year-old Caucasian male that, after failure of several successive antiretroviral regimens, has been successfully treated with a combination of darunavir, a protease inhibitor, and etravirine, a non-nucleoside reverse transcriptase inhibitor. This case report underlines the difficulties of everyday management of HIV-infected patients and the importance of an early identification of resistances and the individualization of the therapy

Downloads

Published

2009-09-15

Issue

Vol. 3 No. 3 (2009)

Section

Case report

License

Authors who publish with this journal agree to the following terms:
    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution Non-Commercial 4.0 Licence that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
    2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. The Publication Agreement can be downloaded here, and should be signed by the Authors and sent to the Publisher when the article has been accepted for publication in this journal.
    3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
    4. Authors are permitted to post their work online after publication (the article must link to publisher version, in html format)